Cargando…

Evaluation of the long-term efficacy and safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto(®)) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe

BACKGROUND: The objective of these two GCP multicentre European clinical field studies was to evaluate the long-term efficacy and safety of a new imidacloprid/flumethrin collar (Seresto(®), Bayer AnimalHealth, Investigational Veterinary Product(IVP)) in dogs and cats naturally infested with fleas an...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanneck, Dorothee, Rass, Julia, Radeloff, Isabel, Kruedewagen, Eva, Le Sueur, Christophe, Hellmann, Klaus, Krieger, Klemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353155/
https://www.ncbi.nlm.nih.gov/pubmed/22463745
http://dx.doi.org/10.1186/1756-3305-5-66
_version_ 1782232999619723264
author Stanneck, Dorothee
Rass, Julia
Radeloff, Isabel
Kruedewagen, Eva
Le Sueur, Christophe
Hellmann, Klaus
Krieger, Klemens
author_facet Stanneck, Dorothee
Rass, Julia
Radeloff, Isabel
Kruedewagen, Eva
Le Sueur, Christophe
Hellmann, Klaus
Krieger, Klemens
author_sort Stanneck, Dorothee
collection PubMed
description BACKGROUND: The objective of these two GCP multicentre European clinical field studies was to evaluate the long-term efficacy and safety of a new imidacloprid/flumethrin collar (Seresto(®), Bayer AnimalHealth, Investigational Veterinary Product(IVP)) in dogs and cats naturally infested with fleas and/or ticks in comparison to a dimpylat collar ("Ungezieferband fuer Hunde/fuer Katzen", Beaphar, Control Product (CP)). METHODS: 232 (IVP) and 81 (CP) cats and 271(IVP) and 129 (CP) dogs were treated with either product according to label claims and formed the safety population. Flea and tick counts were conducted in monthly intervals for up to 8 months in the efficacy subpopulation consisting of 118 (IVP) + 47 (CP) cats and 197 (IVP) + 94 (CP) dogs. Efficacy was calculated as reduction of infestation rate within the same treatment group and statistically compared between the two treatment groups. RESULTS: Preventive efficacy against fleas in cats/dogs varied in the IVP group between 97.4%/94.1% and 100%/100% (overall mean: 98.3%/96.7%) throughout the 8 month period and in the CP group between 57.1%/28.2% and 96.1%/67.8% (overall mean: 79.3%/57.9%). Preventive efficacy against ticks in cats/dogs varied in the IVP group between 94.0%/91.2% and 100%/100% (overall mean: 98.4%/94.7%) throughout the 8 month period and in the CP group between 90.7%/79.9% and 100%/88.0% (overall mean: 96.9%/85.6%). The IVP group was statistically non-inferior to the CP group, and on various assessment days, statistical superiority was proven for flea and tick count reduction in dogs and cats. Both treatments proved to be safe in dogs and cats with mainly minor local observations at the application site. There was moreover, no incidence of any mechanical problem with the collar in dogs and cats during the entire study period. CONCLUSIONS: The imidacloprid/flumethrin collar proved to reduce tick counts by at least 90% and flea counts by at least 95% for a period of at least 7-8 months in cats and dogs under field conditions. Therefore, it can be used as sustainable long-term preventative, covering the whole flea and tick season.
format Online
Article
Text
id pubmed-3353155
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33531552012-05-16 Evaluation of the long-term efficacy and safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto(®)) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe Stanneck, Dorothee Rass, Julia Radeloff, Isabel Kruedewagen, Eva Le Sueur, Christophe Hellmann, Klaus Krieger, Klemens Parasit Vectors Research BACKGROUND: The objective of these two GCP multicentre European clinical field studies was to evaluate the long-term efficacy and safety of a new imidacloprid/flumethrin collar (Seresto(®), Bayer AnimalHealth, Investigational Veterinary Product(IVP)) in dogs and cats naturally infested with fleas and/or ticks in comparison to a dimpylat collar ("Ungezieferband fuer Hunde/fuer Katzen", Beaphar, Control Product (CP)). METHODS: 232 (IVP) and 81 (CP) cats and 271(IVP) and 129 (CP) dogs were treated with either product according to label claims and formed the safety population. Flea and tick counts were conducted in monthly intervals for up to 8 months in the efficacy subpopulation consisting of 118 (IVP) + 47 (CP) cats and 197 (IVP) + 94 (CP) dogs. Efficacy was calculated as reduction of infestation rate within the same treatment group and statistically compared between the two treatment groups. RESULTS: Preventive efficacy against fleas in cats/dogs varied in the IVP group between 97.4%/94.1% and 100%/100% (overall mean: 98.3%/96.7%) throughout the 8 month period and in the CP group between 57.1%/28.2% and 96.1%/67.8% (overall mean: 79.3%/57.9%). Preventive efficacy against ticks in cats/dogs varied in the IVP group between 94.0%/91.2% and 100%/100% (overall mean: 98.4%/94.7%) throughout the 8 month period and in the CP group between 90.7%/79.9% and 100%/88.0% (overall mean: 96.9%/85.6%). The IVP group was statistically non-inferior to the CP group, and on various assessment days, statistical superiority was proven for flea and tick count reduction in dogs and cats. Both treatments proved to be safe in dogs and cats with mainly minor local observations at the application site. There was moreover, no incidence of any mechanical problem with the collar in dogs and cats during the entire study period. CONCLUSIONS: The imidacloprid/flumethrin collar proved to reduce tick counts by at least 90% and flea counts by at least 95% for a period of at least 7-8 months in cats and dogs under field conditions. Therefore, it can be used as sustainable long-term preventative, covering the whole flea and tick season. BioMed Central 2012-03-31 /pmc/articles/PMC3353155/ /pubmed/22463745 http://dx.doi.org/10.1186/1756-3305-5-66 Text en Copyright ©2012 Stanneck et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Stanneck, Dorothee
Rass, Julia
Radeloff, Isabel
Kruedewagen, Eva
Le Sueur, Christophe
Hellmann, Klaus
Krieger, Klemens
Evaluation of the long-term efficacy and safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto(®)) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe
title Evaluation of the long-term efficacy and safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto(®)) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe
title_full Evaluation of the long-term efficacy and safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto(®)) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe
title_fullStr Evaluation of the long-term efficacy and safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto(®)) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe
title_full_unstemmed Evaluation of the long-term efficacy and safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto(®)) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe
title_short Evaluation of the long-term efficacy and safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto(®)) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe
title_sort evaluation of the long-term efficacy and safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar (seresto(®)) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in europe
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353155/
https://www.ncbi.nlm.nih.gov/pubmed/22463745
http://dx.doi.org/10.1186/1756-3305-5-66
work_keys_str_mv AT stanneckdorothee evaluationofthelongtermefficacyandsafetyofanimidacloprid10flumethrin45polymermatrixcollarserestoindogsandcatsnaturallyinfestedwithfleasandorticksinmulticentreclinicalfieldstudiesineurope
AT rassjulia evaluationofthelongtermefficacyandsafetyofanimidacloprid10flumethrin45polymermatrixcollarserestoindogsandcatsnaturallyinfestedwithfleasandorticksinmulticentreclinicalfieldstudiesineurope
AT radeloffisabel evaluationofthelongtermefficacyandsafetyofanimidacloprid10flumethrin45polymermatrixcollarserestoindogsandcatsnaturallyinfestedwithfleasandorticksinmulticentreclinicalfieldstudiesineurope
AT kruedewageneva evaluationofthelongtermefficacyandsafetyofanimidacloprid10flumethrin45polymermatrixcollarserestoindogsandcatsnaturallyinfestedwithfleasandorticksinmulticentreclinicalfieldstudiesineurope
AT lesueurchristophe evaluationofthelongtermefficacyandsafetyofanimidacloprid10flumethrin45polymermatrixcollarserestoindogsandcatsnaturallyinfestedwithfleasandorticksinmulticentreclinicalfieldstudiesineurope
AT hellmannklaus evaluationofthelongtermefficacyandsafetyofanimidacloprid10flumethrin45polymermatrixcollarserestoindogsandcatsnaturallyinfestedwithfleasandorticksinmulticentreclinicalfieldstudiesineurope
AT kriegerklemens evaluationofthelongtermefficacyandsafetyofanimidacloprid10flumethrin45polymermatrixcollarserestoindogsandcatsnaturallyinfestedwithfleasandorticksinmulticentreclinicalfieldstudiesineurope